A
1.65
-0.15 (-8.33%)
| Previous Close | 1.80 |
| Open | 1.77 |
| Volume | 242,984 |
| Avg. Volume (3M) | 83,204 |
| Market Cap | 23,982,914 |
| Price / Sales | 48.84 |
| Price / Book | 0.180 |
| 52 Weeks Range |
| Operating Margin (TTM) | -2,621.65% |
| Diluted EPS (TTM) | -2.76 |
| Quarterly Revenue Growth (YOY) | 109.90% |
| Current Ratio (MRQ) | 0.100 |
| Operating Cash Flow (TTM) | -27.17 M |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Devices (US) | Mixed | Mixed |
| Medical Devices (Global) | Mixed | Mixed | |
| Stock | Adagio Medical Holdings, Inc | - | - |
AIStockmoo Score
0.6
| Analyst Consensus | 0.0 |
| Insider Activity | NA |
| Price Volatility | 0.5 |
| Technical Moving Averages | 2.5 |
| Technical Oscillators | -0.5 |
| Average | 0.63 |
|
Adagio Medical Holdings Inc is an innovator in catheter ablation technologies for treatment of cardiac arrhythmias. The company focuses on developing innovative cryoablation technologies that create contiguous, transmural lesions to treat cardiac arrhythmias, including paroxysmal and persistent atrial fibrillation, atrial flutter, and ventricular tachycardia. |
|
| Sector | Healthcare |
| Industry | Medical Devices |
| % Held by Insiders | 19.66% |
| % Held by Institutions | 91.48% |
No data within this time range.
No data within this time range.
| Date | Type | Details |
|---|---|---|
| 16 Dec 2024 | Announcement | Adagio Medical Announces Appointment of Accomplished Medical Device Leader Todd Usen as Chief Executive Officer and Director |
| 14 Nov 2024 | Announcement | Adagio Medical Reports Third Quarter 2024 Results |
| 04 Nov 2024 | Announcement | Adagio Medical to Present at the Stifel 2024 Healthcare Conference |
| 24 Oct 2024 | Announcement | Adagio Medical Announces Completion of First Procedures in FULCRUM-VT U.S. FDA Pivotal IDE of Ventricular Tachycardia Cryoablation System |
| 07 Oct 2024 | Announcement | Adagio Medical Announces Participation in the 19th Annual International Symposium on Ventricular Arrhythmias |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |